Polymorphisms in the human CYP2D6 gene promoter region and their use in diagnostic and therapeutic applications

Provided are polynucleotides of molecular variant promoters of the CYP2D6 gene which, for example, are associated with abnormal drug response or individual predisposition to several common diseases and disorders caused by drug under- or over-metabolization, and vectors comprising such polynucleotide...

Full description

Saved in:
Bibliographic Details
Main Authors Raimundo, Sebastian, Zanger, Ulrich
Format Patent
LanguageEnglish
Published 06.03.2012
Online AccessGet full text

Cover

Loading…
More Information
Summary:Provided are polynucleotides of molecular variant promoters of the CYP2D6 gene which, for example, are associated with abnormal drug response or individual predisposition to several common diseases and disorders caused by drug under- or over-metabolization, and vectors comprising such polynucleotides. Furthermore, methods of diagnosing the status of disorders related to intermediate metabolization of drugs are described. In addition, kits comprising oligonucleotides hybridizing to the CYP2D6 promoter and/or being capable of being extended into this region useful for diagnosing subjects that are ultrarapid or intermediate metabolizer of drugs are provided.